The Effect of Dual Task Training on Cognitive in Alzheimer's Disease
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This randomized controlled clinical trial aims to evaluate the effectiveness of dual-task training on cognitive functions in patients with Alzheimer's disease. Participants will be randomly assigned to either a dual-task training group or a conventional exercise group. The intervention will last 8 weeks, with three supervised sessions per week. Cognitive performance, mobility, balance, and quality of life will be assessed before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable alzheimer-disease
Started Sep 2025
Shorter than P25 for not_applicable alzheimer-disease
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
September 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedSeptember 9, 2025
September 1, 2025
1 month
August 21, 2025
September 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
d2 Test of Attention
A widely used neuropsychological test evaluating visual attention and processing speed. Participants are asked to quickly and accurately mark target symbols (e.g., the letter "d" with two dashes) among distractors on a sheet consisting of similar letters and symbols.
From enrollment to the end of treatment at 8 weeks
Trail Making Test Part A (TMT-A)
Assesses visual attention, processing speed, and psychological flexibility. The participant is required to connect numbered circles from 1 to 25 in order as quickly as possible.
From enrollment to the end of treatment at 8 weeks
Stroop Test
Stroop Test: Evaluates executive functions and attentional control. The participant must state the ink color of a word rather than reading the written word itself (e.g., the word "Blue" written in red ink should be answered as "red")
From enrollment to the end of treatment at 8 weeks
Trail Making Test Part B (TMT-B):
Trail Making Test Part B (TMT-B): Used to assess executive functions, cognitive flexibility, and attention. The participant alternates between numbers and letters in sequence (1-A-2-B-3-C…)
From enrollment to the end of treatment at 8 weeks
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA): Evaluates memory, attention, executive functions, and visuospatial skills. It is a standard and validated tool for monitoring cognitive status and comparing pre- and post-intervention performance in Alzheimer's patients
From enrollment to the end of treatment at 8 weeks
Secondary Outcomes (13)
Symbol Digit Modalities Test (SDMT)
From enrollment to the end of treatment at 8 weeks
Functional Near-Infrared Spectroscopy (fNIRS)
From enrollment to the end of treatment at 8 weeks
Disability Assessment for Dementia (DAD)
From enrollment to the end of treatment at 8 weeks
Dual Task Protocol
From enrollment to the end of treatment at 8 weeks
Performance Measures: Walking speed
From enrollment to the end of treatment at 8 weeks
- +8 more secondary outcomes
Study Arms (2)
Dual-task motor-cognitive training
EXPERIMENTALParticipants assigned to this group will undergo dual-task motor-cognitive training, which combines physical exercises with simultaneous cognitive tasks. Sessions will last 45-60 minutes, three times per week, for 8 weeks. Exercises will include gait and balance activities performed while engaging in cognitive tasks such as arithmetic, memory recall, or word association.
Conventional Exercise Training
ACTIVE COMPARATORParticipants in this group will receive a conventional exercise program focusing on strength, flexibility, and balance without a cognitive component. Sessions will last 45-60 minutes, three times per week, for 8 weeks, and will be supervised by a physiotherapist.
Interventions
Participants assigned to this group will undergo dual-task motor-cognitive training, which combines physical exercises with simultaneous cognitive tasks. Sessions will last 45-60 minutes, three times per week, for 8 weeks. Exercises will include gait and balance activities performed while engaging in cognitive tasks such as arithmetic, memory recall, or word association.
Participants in this group will receive a conventional exercise program focusing on strength, flexibility, and balance without a cognitive component. Sessions will last 45-60 minutes, three times per week, for 8 weeks, and will be supervised by a physiotherapist.
Eligibility Criteria
You may qualify if:
- Age ≥ 60 years
- Diagnosed with mild-stage Alzheimer's disease (According to DSM-5 or NINCDS-ADRDA criteria)
- MoCA score between 10-25 (Indicating sufficient cognitive capacity for dual-task training)
- Ability to walk independently or with minimal assistance
- Adequate hearing and vision to enable communication
- Physical and mental capacity to participate in the dual-task training protocol
- Provision of written informed consent (signed informed consent form)
You may not qualify if:
- Diagnosis of advanced-stage Alzheimer's disease (MoCA \< 10)
- Presence of additional neurological disorders affecting the motor system (e.g. Parkinson's disease, stroke, multiple sclerosis)
- Severe hearing or vision impairment (inability to respond to visual or auditory stimuli)
- History of psychiatric disorders (e.g., major depression, schizophrenia)
- Orthopedic or cardiopulmonary conditions that would prevent participation in dual-task training
- Participation in another cognitive or physical rehabilitation program within the last 3 months
- Individuals with unstable cognitive status due to recent medication changes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sümeyye AKÇAY, PhD
Fenerbahçe University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 21, 2025
First Posted
September 9, 2025
Study Start
September 1, 2025
Primary Completion
October 1, 2025
Study Completion
May 1, 2026
Last Updated
September 9, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share